|Day's range||1.6000 - 1.6750|
|52-week range||1.5000 - 4.7500|
|PE ratio (TTM)||-0.75|
|Dividend & yield||N/A (N/A)|
|1y target est||N/A|
Rare Disease Week was rapidly followed by more proposals to gut the ACA healthcare and the FDA, immigration and travel bans which will decimate research and healthcare (as well as being needless and cruel), and reduce research budgets. How does this help patients?
Martin Shkreli’s departure and sale of his stake have allowed KaloBios to focus on a turnaround